The abstract is read at the publisher; the summary is JClub's.
Kappa opioid receptor availability measured as V T is significantly lower in multiple brain regions in 20 individuals with borderline personality disorder versus 20 matched healthy controls.
- Why it matters: Kappa opioid receptors are a promising treatment target, but their in vivo status in borderline personality disorder and links to clinical features were previously unexamined.
- What they did: Participants underwent [11C]EKAP PET, with KOR V T quantified in BPD-relevant brain regions of interest and compared between groups, then correlated with impulsivity, depressive symptoms, and trauma symptoms.
- The result: In borderline personality disorder, V T was lower in the amygdala, anterior cingulate, hippocampus, insula, and frontal regions, and it correlated negatively with impulsivity (r28 = -0.45, p = .013) and depressive symptoms (r28 = -0.43, p = .021), but not trauma symptoms.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.